Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Burkitt Lymphoma 35Myelodysplastic Syndromes 34Lymphoma 34Leukemia, Myeloid, Acute 31Leukemia, Myeloid, Chronic-Phase 30Leukemia, Myeloid, Accelerated Phase 28Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Follicular 23Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 22Blast Crisis 22Lymphoma, Large-Cell, Immunoblastic 21Myeloproliferative Disorders 20Multiple Myeloma 20Lymphoma, Mantle-Cell 20Lymphoma, B-Cell, Marginal Zone 20Graft vs Host Disease 20Dendritic Cell Sarcoma, Interdigitating 19Neoplasms, Plasma Cell 18Hodgkin Disease 18Leukemia, Myelomonocytic, Chronic 17Leukemia, Biphenotypic, Acute 17Congenital Abnormalities 17Recurrence 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Anemia, Refractory, with Excess of Blasts 15Primary Myelofibrosis 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

haloperidol decanoate 1glutamic acid diethyl ester 1Vincristine 1Surveys and Questionnaires 1Psychiatric Rehabilitation 1Prednisolone 1Nutritional Status 1Methylprednisolone 1Lorazepam 1Glutamine 1Glutamic Acid 1Exercise 1Dietary Supplements 1Cytarabine 1Baclofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Methylprednisolone × Other hematologic neoplasm × Clear all
NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡